-----:0
Expresses the sense of the Senate that: (1) the Centers for Disease Control and Prevention (CDC) should identify and collect data on racial disparities in the incidence and prevalence of hypertension, and (2) the Department of Health and Human Services should coordinate the collection and analysis of such data with the Department of Defense (DOD), Centers for Disease Control and Prevention (CDC), and the National Heart, Lung, and Blood Institute.
-----:1
This bill amends the Federal Food, Drug, and Cosmetic Act to permit the Centers for Disease Control and Prevention to revise the guidelines for prostate cancer screening to include additional information on the content of tomato products and prostate cancer.
-----:2
Chronic hcv infection and liver fibrosis: A descriptive study - Amends the Federal Food, Drug, and Cosmetic Act to provide new criteria for treating chronic hcv infection. Defines: (1) "chronic hcv infection" as infection that is mild in serum transaminase levels and not significant clinical symptoms; and (2) "chronic liver fibrosis" as fibrosis that is associated with hcv infection, but not with cirrhosis. Provides guidelines for treating chronic hcv infection.
-----:3
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration (HRSA), to report to Congress regarding the policies and practices of foreign countries regarding replacement blood donors.
Directs the Secretary to establish a pilot program in the United States for the development and implementation of policies and practices for voluntary blood donor procurement. Requires the Secretary to report to Congress regarding such programs and the extent to which foreign countries are implementing such policies and practices.
-----:4
protein interaction network analysis - Provides for the use of a protein interaction network to identify similar instances of protein interaction patterns within a collection of networks and netscape ranges of proteins.
-----:5
Disulfiram should be used at the lowest effective dose, possibly 250 mg per day, first intake only without any additional requirement of anti - psychotic treatment.
-----:6
Directs the Secretary of Health and Human Services (HHS) to report to Congress regarding the use of a specified pesticide to control malfestina insects.
-----:7
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to ensure that the data from this study are made available to the public and posted on the CDC website.
-----:8
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the National Institute of Diabetes and Digestive and Kidney Diseases to: (1) conduct research to expand the understanding of the role of srage activation in diabetes; and (2) support the development of new technologies to improve the diagnosis, prevention, and treatment of diabetes.
-----:9
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:10
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study on the status of small cell carcinoma of the bladder, and to report on the results of such study.
-----:11
Entitles the Secretary of Health and Human Services to provide any assistance necessary to carry out this Act, and to request that the Institute of Medicine report its recommendations to the Congress.
-----:12
Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC to: (1) collect and analyze data on medblastoma, (2) evaluate the role of human polyoma virus and medullosis in medblastoma, and (3) conduct basic, clinical, and translational research with respect to medblastoma.
-----:13
Expresses the sense of the Senate that: (1) the Food and Drug Administration (FDA) should issue guidance on the use of bexal antimicrobials, and (2) the Centers for Disease Control and Prevention (CDC) should develop a database to track changes in bacterial resistance to bexal antimicrobials. Amends the Federal Food, Drug, and Cosmetic Act to require the FDA to issue guidance on the use of bexal antimicrobials in hospital settings.
-----:14
Allows the use of a non-operative approach to the treatment of femorotabular impingement in professional athletes with such an injury if the approach involves less post-return, including professional athletes, to return to high functioning.
-----:15
Imposes a fine or imprisonment (or both) of up to $10,000 for specified violations of this Act or of related laws, or both.
-----:16
TABLE OF CONTENTS: 
 Title I: Tay-Sachs 
 Title II: Genetic Epidemiology 
 Title III: Radiological and Medical Research 
Title I: Tay-Sachs
 - Directs the Secretary of Health and Human Services to conduct a study to determine the prevalence and distribution of Tay-Sachs. 
Title II: Genetic Epidemiology
 - Directs the Secretary to conduct a study to determine the prevalence and distribution of Tay-Sachs in children. Authorizes the Secretary to make grants to public or nonprofit private entities for the purpose of conducting this study.
-----:17
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an arrangement with the National Cancer Institute to conduct a study on the status of primary cutaneous melanoma, the incidence and prognosis of such cancer, in elderly women.
-----:18
Recognizes the effect of certain additional factors on the determination of transcription value, including the extent to which certain factors are involved in tissue differentiation.
-----:19
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) review the current state of the science relating to the diagnosis of pji (a disease of the spine) and develop recommendations to improve the accuracy of pji diagnostic tests, (2) assist the CDC in developing these recommendations, and (3) convene an advisory panel to assist in developing the recommendations.

Requires the Secretary to: (1) review the current state of the science relating to the diagnosis of pji with respect to the use of pji biomarkers, (2) identify those research items that have the greatest potential to improve the accuracy of pji diagnostic tests, and (3) develop recommendations to improve the accuracy of pji diagnostic tests.
-----:20
Expresses the sense of the Congress that: (1) the Food and Drug Administration should issue specific guidance on the labeling of certain anticancer drugs, including those that may cause melting of cells in the eye; and (2) the Department of Health and Human Services should contract with an independent entity to evaluate the safety of these drugs for labeling purposes.
-----:21
Directs the Secretary of Health and Human Services to promulgate regulations for the safety of human oral health and the use of solvent-based dental bonding agents.
-----:22
Expresses the sense of the United States that: (1) NIH should support the ongoing efforts of these scientists to gain a better understanding of the mechanisms by which proteins within the nuclear envelope interact with each other and with the tissues in which they operate; (2) the National Institutes of Health should support the efforts of these scientists to expand their understanding of the mechanisms by which proteins within the nuclear envelope interact with each other and with the tissues in which they operate; and (3) the Centers for Disease Control and Prevention should support the efforts of these scientists to expand their understanding of the mechanisms by which proteins within the nuclear envelope interact with each other and with the tissues in which they operate.
-----:23
Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to submit to the appropriate congressional committees a report on the status of macrolideerythromycin resistance.
-----:24
This report describes a case of pseudozymais fung infiltration, which was reported as an invasive result of chemotherapy after reinduction of the blood drug cytarabine.
-----:25
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the Director of the National Heart, Lung, and Blood Institute, through grants or cooperative agreements, to: (1) conduct research related to the relationship between diabetes and certain conditions, including foot ulcerations; and (2) evaluate the current state of knowledge regarding such relation.
-----:26
Authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into cooperative agreements with the National Heart, Lung, and Blood Institute to: (1) collect and analyze data on the incidence and prevalence of a1180v mutation in the National Heart, Lung, and Blood Institute database; and (2) conduct or support research to expand the understanding of the pathogenesis, diagnosis, and treatment of a1180v mutation.
Directs the Secretary, acting through the Director of the CDC, to: (1) collect and analyze data on the incidence and prevalence of a1180v mutation in the National Heart, Lung, and Blood Institute database; and (2) conduct or support research to expand the understanding of the pathogenesis, diagnosis, and treatment of a1180v mutation.
-----:27
Allows the use of traternal ultrasound to determine the location of retinal detachments.
-----:28
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the Centers with respect to the research, prevention, and treatment of human disease.
-----:29
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate research programs to evaluate the relationship between obesity and acute coronary heart disease, nondipping patterns of bp, and certain other risk factors.

Directs the Secretary to: (1) conduct or support research to evaluate the relationship between obesity and acute coronary heart disease, nondipping patterns of bp, and certain other risk factors; and (2) expand, intensify, and coordinate research programs to evaluate such relationship.
-----:30
dental additive manufacturing system - Provides for the establishment of an advisory committee to evaluate and make recommendations to the Secretary of Health and Human Services on the development and implementation of an automated dental additive manufacturing system.
-----:31
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to conduct a study to determine the incidence and prevalence of certain conditions that cause breakage of hair.
-----:32
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the course and incidence of cardiac toxicity in patients with relapsing multiple sclerosis who received mitoxantrone therapy during the period beginning on January 1, 2004, and ending on June 1, 2008; and (2) report on such data to the appropriate congressional committees.
-----:33
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to provide assistance to the National Institutes of Health in the development and operation of a program to improve the diagnosis, prevention, and treatment of human diseases through the use of target proteins encoded by specified members of certain families ofphosphoenone residues.
-----:34
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate research programs to: (1) evaluate the relationship between vitamin d levels and liver inflammation; (2) evaluate the effect of vitamin d on the development of chronic liver disease; and (3) conduct or support research to expand the understanding of the causes of liver disease.
-----:35
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide for the conduct or support of clinical trials to evaluate the safety and effectiveness of alternative approaches for the treatment of prostate cancer, including: (1) a prospective study that compares the efficacy and safety of different approaches, and (2) a clinical trial to evaluate the safety and effectiveness of a new approach.
-----:36
Case report of a 66-year old man who presented to our hospital with complaints of shortness of breath, but who did not show any lung parenmal abnormality, and who was diagnosed as having a pulmonary extramedry hematopoiesis causing severe tricuspidis in his lungs.

Defines extramedry hematopoiesis in the lungs as a multifactorial factor that is suspected to be the cause of pulmonary extramedry hematopoiesis in the lungs.
-----:37
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand the research programs of the National Institutes of Health (NIH) related to the use of dsbs on mitotic chromosomes.
-----:38
Directs the Secretary of Health and Human Services to conduct or support research, and report to the appropriate congressional committees, on the mechanisms by which the Food and Drug Administration (FDA) determines the safety and effectiveness of certain drugs used to treat melanoma.
-----:39
This bill authorizes the Department of Health and Human Services to award grants, contracts, or cooperative agreements to public or nonprofit private entities for the research, development, demonstration, and commercial application of therapies that may be used to prevent or treat conditions that are susceptible to neurotrophic factors. The terms of such grants, contracts, or cooperative agreements may include a provision for the identification, research, development, demonstration, or commercial application of a specific neurotrophic factor.
-----:40
Authorizes the Secretary of Health and Human Services to provide grants to eligible public or nonprofit private entities to carry out research relating to the diagnosis, prevention, and treatment of biliary hamartomas. Authorizes appropriations.
-----:41
Human Rights Protection Act of 2016 This bill authorizes the President to provide assistance, including through international organizations, national governments, and international and local nongovernmental organizations, to promote and ensure access to health and mental health services, information, education, and prevention programs for people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity. It expresses the sense of the Congress that the President, acting through the United States Agency for International Development (USAID), should: review all laws in Nigeria that prohibit, restrict, or otherwise deny people whose rights are not on the basis of their gender identity or gender identity from seeking health and mental health services; promote and ensure access to health and mental health services, information, education, and prevention programs for people whose rights are not on the basis of their gender identity or gender identity because of their sexual orientation or gender identity; and review all laws in Nigeria that prohibit, restrict, or otherwise deny people whose rights are not on the basis of their gender identity or gender identity from seeking health and mental health services. It expresses the sense of the Congress that the President should: review all laws in Nigeria that prohibit, restrict, or otherwise deny people whose rights are not on the basis of their gender identity or gender
-----:42
Long-Term Care Insurance Program in Korea - Amends the korean long-term care insurance program to revise the criteria for determining whether a nursing facility is eligible for coverage under such program. Establishes a formula for determining the grade of a facility for purposes of determining whether it is eligible for such coverage.
-----:43
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to provide assistance to develop and implement a comprehensive strategy to reduce the incidence and mortality caused by extrahec portal hypertension (evovo sepsis) around the world by carrying out activities to improve the diagnosis, prevention, and treatment of such disease. Authorizes appropriations.
-----:44
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Heart, Lung, and Blood Institute to conduct a study to review the current state of the science relating to the repair of heart valves.
-----:45
Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to convene a panel of experts to review and make recommendations on the current state of knowledge about mes (a cluster of inflammatory conditions associated with diabetes that may play a causal role in insufficient physical activity, insufficient physical activity accompanied with increased or inappropriate fat accumulation, and may increase the risk of cardiovascular disease). Directs the Secretary to: (1) convene such panel every two years to review and make recommendations on what is currently known about mes; and (2) report to the Congress on its findings.
-----:46
Authorizes the Secretary of Health and Human Services to provide for the conduct or support of additional educational interventions for medical students that would improve their prescribing skills.
-----:47
Washington, D.C. Admission and Immigrant Responsibility Act of 2005 - Amends the Immigration and Nationality Act to exclude from the definition of "immigrant" a person who has entered the United States unlawfully from a country whose residents are subject to deportation for certain offenses, including use of drugs or alcohol.

Authorizes the Secretary of Health and Human Services to waive such prohibition if in the national interest.

Requires the Secretary to: (1) provide information to immigrants regarding risks of contracting tuberculosis (TB) in the United States; and (2) develop and implement a program to reduce the number of TB cases among immigrants.

Authorizes appropriations.
-----:48
TABLE OF CONTENTS: 
 Title I:report on hospital-acquired vancomycin resistance 
 Title II: reporting of hospital-acquired vancomycin resistance 
Title I:report on hospital-acquired vancomycin resistance
 - Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report on reports of hospital-acquired vancomycin resistance. 
Title II: reporting of hospital-acquired vancomycin resistance
 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to report on reported vancomycin resistance.
-----:49
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect and analyze data on the use of villiptin as an antidiabetic and report it to the CDC; and (2) determine whether villiptin may pose a significant risk to patients with diabetes, and whether the risks of villiptin exposure outweighs its benefits.
-----:50
2010oc 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to increase the number of specimens analyzed for enterovirus infections in the National Institute of Allergy and Infectious Diseases. Directs the Secretary to: (1) increase the number of specimens analyzed for enterovirus in the Centers for Disease Control and Prevention (CDC); and (2) contract with the Institute to conduct an analysis of such enterovirus strains.
-----:51
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to eligible public or nonprofit private entities to carry out a program to educate the public and health care providers about dysphagia, and the treatment of such condition. Authorizes appropriations.
-----:52
Provides for the conduct of a study to evaluate the efficacy of specific techniques for the repair of human spleen injuries, including strategies to: (1) prevent or minimize the development of complications; (2) treat the spleen as an organ with respect to which treatment may be necessary; and (3) improve the quality of life for individuals with such injuries. Directs the Secretary of Health and Human Services to conduct a study to evaluate the effectiveness of specific techniques for the repair of human spleen injuries, including strategies to: (1) prevent or minimize the development of complications; (2) treat the spleen as an organ with respect to which treatment may be necessary; and (3) improve the quality of life for individuals with such injuries.
-----:53
Drug delivery system: A system for delivering a drug through the skin to provide a convenient, cost-effective, and safe method for the delivery of a drug.
-----:54
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide for a review of current research relating to the impact of physical activity on rheumatoid arthritis patients and identify areas for further research.
-----:55
TABLE OF CONTENTS: 
 Title I: Food Amendments 
 Title II: Sugar Amendments 
Food Amendments and the Public Health Service Act of 1986 - 
Title I: Food Amendments
 - Amends the Federal Food, Drug, and Cosmetic Act to modify the definition of food to include: (1) sugar (including corn syrup), whether in food form or as an ingredient in beverages; and (2) any other sugars, whether in food form or as an ingredient in beverages. 
Requires the Secretary of Health and Human Services to issue regulations to modify the definition of food to include: (1) sugar (including corn syrup), whether in food form or as an ingredient in beverages; and (2) any other sugars, whether in food form or as an ingredient in beverages. 
Directs the Secretary to issue regulations to prohibit the sale of any food or beverage containing sugar if the Secretary determines that there is credible evidence that the food or beverage contains sugar, whether in food form or as an ingredient in beverages, and if this is the case there should be no sale of such food or beverage to the general public. 
Title II: Sugar Amendments
 - Amends the Public Health Service Act of 1986 to require the Secretary to promulgate regulations to modify
-----:56
Expresses the sense of the Congress that: (1) the Department of Health and Human Services should support the continued expansion and advancement of this study; and (2) the National Institutes of Health should ensure that the results are made available to the public as soon as possible.
-----:57
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study on the use of targeted therapeutic treatments for the prevention, eradication, and control of meningiomas.
-----:58
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to report to the appropriate congressional committees on the case of a man who died from tuberculosis after being treated with antituberculosis drugs.
-----:59
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to ensure that the guidelines developed by the Food and Drug Administration (FDA) for the use of certain serum analytes in clinical laboratories are updated to reflect the latest information regarding the stability of these analytes in serum storage.
-----:60
United States Food and Nutrition Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to expand the definition of food to include milk and food ingredients.
-----:61
Directs: (1) the Director of the National Institutes of Health to expand, intensify, and coordinate the collection and analysis of data on conserved proteins in the human genome for research purposes; and (2) the Secretary of Health and Human Services to make such collection and analysis available to the public for free on the Internet.
-----:62
Tuberculosis Research Act of 2010 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities of the CDC in response to the significant increase in cases of tuberculosis in Russia.

Requires the Secretary to: (1) increase the number of surveillance systems for tuberculosis; (2) expand the scope of surveillance systems for other infectious diseases; and (3) establish a system for the collection, analysis, and reporting of data on tuberculosis.

Requires the Director of the CDC, acting through the Director of the National Heart, Lung, and Blood Institute, to: (1) expand, intensify, and coordinate activities of the Centers for Disease Control and Prevention (CDC) in response to the significant increase in cases of tuberculosis in Russia; and (2) establish a system for the collection, analysis, and reporting of data on tuberculosis.
-----:63
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the National Cancer Institute to conduct a study to evaluate the impact of oral administration of pde5-is on the penile rehabilitation of prostate cancer patients.
-----:64
Directs the Secretary to take necessary action to develop and report to the appropriate agencies on the implementation and performance of multi-color qd lasers using implantation induced intermixing.
-----:65
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to Congress on the status of the use of lincomycin and pirlindycin as antimicrobial drugs.
-----:66
Amends the Public Health Service Act to authorize the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants to certain nonprofit private entities for the development and implementation of demonstration programs to evaluate the effectiveness of the combination of chemotherapy and fluorouracil/methyl tertiary-butyl ether as a treatment for advanced penile cancer.
-----:67
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand, intensify, and coordinate activities related to the prevention and control of human hook infection.
-----:68
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) undertake a comprehensive study to determine the prevalence and clinical characteristics of ovov and whether it is the cause of severe pediatric gastroenteritis in countries with a high incidence of such infections; and (2) report the results of such study to the Congress.
-----:69
Multicystic dysplastic kidney syndrome is a dominant condition that results from abnormalities of the kidney and is associated with other multisystemic disorders.
-----:70
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the science relating to the use of blood serum as a diagnostic tool for cardiovascular disease.
-----:71
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of the development of antiangiogenic therapy based upon certain biomarkers.
-----:72
(This measure has not been amended since it was reported to the House on May 14, 2014. This measure has not been amended since it was reported to the House on May 14, 2014.
-----:73
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make available to the public: (1) information on the safety and effectiveness of intravitreal injections of a specified drug for the treatment of age-related retinal degeneration; and (2) assistance in disseminating such information to health care providers.
-----:74
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate research programs to: (1) improve the safety and performance of dental bleaching materials and restorative materials; and (2) evaluate the efficacy of new materials and technologies.
-----:75
Directs the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to enter into an agreement with the Institute of Medicine to conduct a study to review the current state of knowledge about the effectiveness and safety of the flexible brooscopy procedure. Requires the Secretary to report to the appropriate congressional committees on the study and to make recommendations for appropriate improvements in the performance of such procedure.
-----:76
metabolic syndrome is a simple measure of risk factors for diabetes and cardiovascular disease that is used to determine the prevalence of metabolic syndrome in the Indian population.
-----:77
Directs the Secretary, acting through the Director of the Centers for Disease Control and Prevention, to report to the appropriate congressional committees on the status of research efforts to determine the pathogenesis and pathophysiology of rheumatoid arthritis.
-----:78
Expresses the sense of the Congress that the Department of Health and Human Services should provide for the conduct and support of research into the relationship between dietary intake of soy products and the development of prostate cancer in American men.
-----:79
This bill directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research efforts to: (1) identify new targets of micrornablastoma, (2) evaluate the role of specified molecules in the signaling system of micrornablastoma and other cancers, and (3) identify new targets of micrornablastoma for therapeutic purposes.
-----:80
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review and make recommendations on: (1) ablative laser treatment that may be used to reduce and prevent skin aging, and (2) other methods to reduce and prevent skin aging.
-----:81
Directs the Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality, to convene a panel of experts to review the current state of the analytical method for determining concentration with high sensitivity of cardiac biomarkers in patients with acute coronary syndrome, and to submit recommendations to the Secretary for improvements in such method.
-----:82
Reports on a case of panniculitis that was associated with major mortality.
-----:83
TABLE OF CONTENTS: 
 Title I: Laboratory Quality Management 
 Title II: Laboratory Safety 
 Title III: Miscellaneous Provisions 
 Laboratory Safety Act of 1998 - 
Title I: Laboratory Quality Management
 - Sets forth the objectives of this Act to provide for the establishment of laboratory quality management policies, procedures, and practices to reduce errors in laboratory testing point-of-care (poct) errors. 
Title II: Laboratory Safety
 - Amends the Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to prescribe regulations to implement such quality management policies, procedures, and practices as are consistent with the objectives of this Act. 
Title III: Miscellaneous Provisions
 - Amends the Laboratory Safety Act of 1998 to provide that nothing in such regulations shall require the operator of a laboratory to take any action that may adversely affect the safety of a test result.
-----:84
Expresses the sense of the Senate that the Department of Health and Human Services should support efforts by the Institute of Sport and Physical Education of the university of tunisia to collect and analyze data on students' participation in athletics and gymnastics at the school, and to ensure that such data are made available to the public.
-----:85
Provides that, upon the recommendation of the American Heart, Lung, and Blood Institute, the Secretary of Health and Human Services, the Secretary of Defense, and the Administrator of the Agency for Healthcare Research and Quality, the Secretary of Health and Human Services shall review the evidence relating to the use of therapeutic hypothermia after cardiac arrest to determine whether it may provide additional protection against inflammatory effects of cooling following cardiac arrest.
-----:86
Nuclear Regulatory Commission Act of 1978 - Directs the Secretary of Energy, acting through the Director of the Nuclear Regulatory Commission (NRC), to submit to the Congress a report containing: (1) an analysis of specified factors that affect the performance of the multi-barrier design concept proposed for the long-term ( 10 year) storage of high level nuclear wastes in the deep subsurface; (2) a description of specified measures that have been taken to address failures of the multi-barrier design concept over the past 10 years; and (3) a description of measures that can be taken in future years to mitigate and prevent further failures of the design concept.
-----:87
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to, or enter into contracts with, public or nonprofit private entities to carry out this study. Authorizes appropriations.
-----:88
Expresses the sense of the Congress that: (1) the Food and Drug Administration should comprehensively review the scientific evidence relating to the safety and effectiveness of vitamin E supplementation in women's bodies; and (2) the Department of Health and Human Services should promulgate regulations to ensure that women are provided with accurate information about the safety and effectiveness of vitamin E supplementation in women's bodies.
-----:89
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate the testing programs of the National Institutes of Health for the detection and testing of traumatic brain injury. Authorizes the Secretary to make grants to nonprofit private entities for the development and operation of testing programs that will test the efficacy of new medical technologies in the treatment of traumatic brain injury.
-----:90
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to provide assistance to the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate research programs related to asthma and migraine.
-----:91
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) initiate a study to review the current state of technology for bracket bonding using self-bonding systems and to identify gaps in this technology's capabilities; and (2) provide, upon the request of a patient, technical assistance to assist in the implementation of such technology.
-----:92
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to expand, intensify, and coordinate activities of the National Institute on Child Health and Human Development to: (1) conduct research to expand the understanding of the mechanisms by which bone diseases arise, to determine the pathogenesis and pathophysiology of such diseases, and to identify new risk and protective factors; and (2) provide technical assistance to the Institutes of Health and Human Services in carrying out such activities.
-----:93
Requires the Secretary, acting through the Director of the National Institutes of Health, to report to the appropriate congressional committees regarding the extent to which the variations reported in this report are consistent with the results of other research on cnvs from representative populations.
-----:94
Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to convene a panel of experts to review the current state of knowledge about the role of certain transcription factors in the inflammatory response following traumatic brain injury and whether they contribute to such response.
-----:95
Big Data in Critical Care discusses the use of data in critical care with a focus on the big data that is sweep of digital medical information that has accumulated in the clinical setting and the use of scoring systems to assess the severity of acute care.
-----:96
Prohibits the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), from establishing or enforcing standards for the collection of antibiogram data from hospitals for which specified antimicrobial agents are used.
-----:97
Preliminary results from the 2010 H1n1 pandemic influenza surveillance study are described.
-----:98
bilateral shoulder dislocations are the most type of injury without any traumatic seizure disorder and involve only certain cases of such injury.
-----:99
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to enter into an agreement with the National Academy of Sciences (NAS) to review the existing data on the ns cohort and assess its significance for the prevention of obesity and related health outcomes.
Directs the Secretary to: (1) enter into a cooperative agreement with the NAS to review the existing data on the ns cohort and assess its significance for the prevention of obesity and related health outcomes; and (2) conduct or support research to expand the understanding of the determinants of obesity and related health outcomes in the ns cohort.
